Eton Pharmaceuticals (ETON)
(Delayed Data from NSDQ)
$15.26 USD
+0.53 (3.60%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $15.29 +0.03 (0.20%) 7:58 PM ET
4-Sell of 5 4
D Value C Growth F Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ETON 15.26 +0.53(3.60%)
Will ETON be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ETON based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ETON
Eton Pharmaceuticals, Inc. (ETON) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Eton Pharmaceuticals (ETON) Upgraded to Buy: Here's Why
ETON: What are Zacks experts saying now?
Zacks Private Portfolio Services
Eton Pharmaceuticals (ETON) Is a Great Choice for 'Trend' Investors, Here's Why
Eton Pharmaceuticals, Inc. (ETON) Q1 Earnings Lag Estimates
TELA Bio, Inc. (TELA) Reports Q1 Loss, Tops Revenue Estimates
Other News for ETON
Eton Pharmaceuticals to Report Second Quarter 2025 Financial Results on Thursday, August 7, ...
BlackRock, Inc. Expands Stake in Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc (ETON) Shares Up 8.03% on Jul 18
Eton Pharma Near Term Catalysts Vanish
Eton Pharmaceuticals management to meet with B. Riley